Brief: Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025
28/03/2025 12:37
March 28 (Reuters) - Immunoprecise Antibodies Ltd IPA.O: IMMUNOPRECISE ANTIBODIES (IPA) REPORTS FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS FOR THIRD QUARTER FISCAL YEAR 2025 Source text: ID:nBw4pM4xDa Further company coverage: IPA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai